Literature DB >> 1247336

Serum bile acids in primary biliary cirrhosis.

J R Bloomer, R M Allen, G Klatskin.   

Abstract

Fasting serum bile acid levels were measured by gas-liquid chromatography in 56 patients with primary biliary cirrhosis. Of these, 52 (93%) had increased levels (greater than 2mug/ml), including 14 of the 18 with normal serum bilirubin concentrations. The four patients with normal bile acid levels had early lesions as judged by histological and clinical criteria. With progression of the disease, as indicated by the histological features of the lesions, total bile acid levels increased, and the ratio of serum cholic-to-chenodeoxycholic acid decreased. Ratios of serum cholic-to-chenodeoxycholic acid below 1 occurred predominantly in patients with advanced or terminal disease. These studies suggest that serial measurement of serum bile acids may aid in the evaluation of primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247336

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

Review 1.  Serum bile acids in hepatobiliary disease.

Authors:  I A Bouchier; C R Pennington
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

2.  Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.

Authors:  L Qiao; E Studer; K Leach; R McKinstry; S Gupta; R Decker; R Kukreja; K Valerie; P Nagarkatti; W El Deiry; J Molkentin; R Schmidt-Ullrich; P B Fisher; S Grant; P B Hylemon; P Dent
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

3.  Diagnostic value of serum bile acids and routine liver function tests in hepatobiliary diseases. Sensitivity, specificity, and predictive value.

Authors:  R Ferraris; G Colombatti; M T Fiorentini; R Carosso; W Arossa; M De La Pierre
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

Review 4.  Clinical, histologic, and immunopathologic features of primary biliary cirrhosis.

Authors:  H Popper; F Paronetto
Journal:  Springer Semin Immunopathol       Date:  1980-12

5.  Serum bile acids in the diagnosis of hepatobiliary disease.

Authors:  C R Pennington; P E Ross; I A Bouchier
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

6.  Physiological factors influencing serum bile acid levels.

Authors:  M Ponz De Leon; G M Murphy; R H Dowling
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

7.  Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes.

Authors:  Y A Kesäniemi; T A Miettinen; M P Salaspuro
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

8.  Serum bile acids in alcoholic liver disease. Comparison with histological features of the disease.

Authors:  H J Milstein; J R Bloomer; G Klatskin
Journal:  Am J Dig Dis       Date:  1976-04

9.  Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes.

Authors:  Liang Qiao; Song Iy Han; Youwen Fang; Jong Sung Park; Seema Gupta; Donna Gilfor; George Amorino; Kristoffer Valerie; Linda Sealy; John F Engelhardt; Steven Grant; Philip B Hylemon; Paul Dent
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

10.  Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling.

Authors:  Guo Zhang; Margaret A Park; Clint Mitchell; Teneille Walker; Hossein Hamed; Elaine Studer; Martin Graf; Mohamed Rahmani; Seema Gupta; Philip B Hylemon; Paul B Fisher; Steven Grant; Paul Dent
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.